Avalo Therapeutics, Inc. (AVTX): SCHEDULE 13G/A filed Jan 29, 2026

Form type

SCHEDULE 13G/A

Filing date

Jan 29, 2026

Accession number

0001315863-26-000095

Filer

Avalo Therapeutics, Inc. (CIK 1534120)